March 1, 2021, 11:46

Labs Across US Join CDC’s New Initiative to Study COVID-19 Genome

Labs Across US Join CDC’s New Initiative to Study COVID-19 Genome

The US Centers for Disease Control and Prevention (CDC) revealed Thursday that at least 75 public health, academic and commercial institutions are collaborating to study the genome of the COVID-19 coronavirus.

The initiative has been dubbed Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES). Its goal is to conduct “large-scale, rapid genomic sequencing of the virus that causes COVID-19.” The initiative will involve 37 state and local public health laboratories, as well as clinical diagnostic corporations and academic and nonprofit institutions across the US.

A report by the New York Times explains how “tiny mutations accumulate” in the novel coronavirus’s genetic code as it replicates. Scientists can track and investigate the replications to develop an understanding of how the virus is evolving over time.

The CDC predicts that the research from the initiative will help officials “gain important insights to support contact tracing” and will “better align sequencing requirements and resource needs with different sources of funding, technology, expertise and other means of support.”

Gene sequences have previously been shared among researchers to better understand and track influenza, and the method was also used in response to Ebola outbreaks in several African countries, according to the New York Times.


Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies. You can find a detailed description in our Privacy Policy.